NCT05586178

Brief Summary

This study investigates different ways to elevate intentions to get the COVID-19 booster via text-based reminders, including providing information about the booster and leveraging the consistency principle. The proposed randomized controlled trial will examine the impact of these reminders on booster uptake.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
177,720

participants targeted

Target at P75+ for not_applicable covid19

Timeline
Completed

Started Oct 2022

Typical duration for not_applicable covid19

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 17, 2022

Completed
1 day until next milestone

Study Start

First participant enrolled

October 18, 2022

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 19, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

December 5, 2024

Status Verified

December 1, 2024

Enrollment Period

2 months

First QC Date

October 17, 2022

Last Update Submit

December 4, 2024

Conditions

Keywords

COVID19VaccinesText-messagesPatient OutreachBehavioral ScienceInformation provision

Outcome Measures

Primary Outcomes (2)

  • booster take-up in 2 weeks

    Whether people receive the bivalent booster at any location reporting to the California Immunization Registry (CAIR)

    2 weeks after getting the text message

  • booster take-up in 4 weeks

    Whether people receive the bivalent booster at any location reporting to the California Immunization Registry (CAIR)

    4 weeks after getting the text message

Secondary Outcomes (1)

  • Link click rate in 1 week

    1 week after getting the text message

Study Arms (7)

Holdout

NO INTERVENTION

Simple reminder

EXPERIMENTAL
Behavioral: Reminder that facilitates action

Consistency reminder

EXPERIMENTAL
Behavioral: Reminder that facilitates actionBehavioral: Consistency framing

Uniqueness information reminder

EXPERIMENTAL
Behavioral: Reminder that facilitates actionBehavioral: Information provision about the uniqueness of the bivalent booster

Eligibility information reminder

EXPERIMENTAL
Behavioral: Reminder that facilitates actionBehavioral: Information provision about bivalent booster eligibility

Severity information reminder

EXPERIMENTAL
Behavioral: Reminder that facilitates actionBehavioral: Information provision about the severity of COVID-19 symptoms

Consistency and uniqueness information reminder

EXPERIMENTAL
Behavioral: Reminder that facilitates actionBehavioral: Consistency framingBehavioral: Information provision about the uniqueness of the bivalent booster

Interventions

Patients will receive a text message reminding them that they can now get the bivalent COVID-19 booster and facilitating action. The message will contain a link to schedule a booster appointment at UCLA Health and a link to vaccine.gov (where people can find local pharmacies that carry the bivalent booster).

Consistency and uniqueness information reminderConsistency reminderEligibility information reminderSeverity information reminderSimple reminderUniqueness information reminder

The message will leverage the psychological principle of consistency. It will highlight to patients that based on medical records, they have completed a COVID-19 vaccine primary series, have done a great job protecting their health, and can now get the bivalent booster.

Consistency and uniqueness information reminderConsistency reminder

The message will contain information about how the bivalent booster differs from previous doses patients have received and why it is valuable.

Consistency and uniqueness information reminderUniqueness information reminder

The message will clarify to patients that regardless of whether they are at high risk, received the original boosters, or previously got COVID-19, they are eligible for the bivalent booster based on their medical records, and the updated booster will be valuable for them.

Eligibility information reminder

The message will contain information about the often underestimated chances of people developing severe or long-lasting COVID-19 symptoms. The message will also mention that the bivalent booster can reduce such chances.

Severity information reminder

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18 or above
  • Have a mobile phone number or SMS-capable phone number in UCLA Health's database
  • Having completed a COVID-19 vaccine primary series based on CAIR data
  • Last COVID-19 vaccine shot (including booster shot) occurred at least two months before the date when patient list are pulled in preparation for the trial, based on CAIR data. The last two criteria meant to identify patients who are eligible for the updated booster.

You may not qualify if:

  • Patients who have received the bivalent booster anywhere (based on CAIR data) before the day they receive the text message
  • Patients who have already scheduled appointments at UCLA Health for getting the bivalent booster before the day they receive the text message

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCLA Health Department of Medicine, Quality Office

Los Angeles, California, 90095, United States

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 17, 2022

First Posted

October 19, 2022

Study Start

October 18, 2022

Primary Completion

December 31, 2022

Study Completion

December 31, 2023

Last Updated

December 5, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations